Your browser doesn't support javascript.
loading
Kindlin-2-miR-1258-TCF4 feedback loop promotes hepatocellular carcinoma invasion and metastasis.
Lin, Wansong; Lin, Jie; Li, Jieyu; Lin, Ying; Chen, Shuping; Wu, Yijuan; Chen, Lingfeng; Cheng, Hui; Liu, Lin; Chen, Xiaoyan; Ye, Yunbin.
Afiliação
  • Lin W; Laboratory of Immuno-Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No.420, Fuma Road, Jinan District, Fuzhou, 350014, Fujian, China.
  • Lin J; Fujian Key Laboratory of Translational Cancer Medicine, No.420, Fuma Road, Jinan District, Fuzhou, 350014, Fujian, China.
  • Li J; Department of Pathology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, No.134, Dong Street, Gulou District, Fuzhou, 350001, Fujian, China. sllinjie@163.com.
  • Lin Y; Laboratory of Immuno-Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No.420, Fuma Road, Jinan District, Fuzhou, 350014, Fujian, China.
  • Chen S; Fujian Key Laboratory of Translational Cancer Medicine, No.420, Fuma Road, Jinan District, Fuzhou, 350014, Fujian, China.
  • Wu Y; Department of Pathology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, No.134, Dong Street, Gulou District, Fuzhou, 350001, Fujian, China.
  • Chen L; Laboratory of Immuno-Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No.420, Fuma Road, Jinan District, Fuzhou, 350014, Fujian, China.
  • Cheng H; Fujian Key Laboratory of Translational Cancer Medicine, No.420, Fuma Road, Jinan District, Fuzhou, 350014, Fujian, China.
  • Liu L; Department of Pathology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, No.134, Dong Street, Gulou District, Fuzhou, 350001, Fujian, China.
  • Chen X; Department of Pathology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, No.134, Dong Street, Gulou District, Fuzhou, 350001, Fujian, China.
  • Ye Y; Department of Pathology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, No.134, Dong Street, Gulou District, Fuzhou, 350001, Fujian, China.
J Gastroenterol ; 57(5): 372-386, 2022 05.
Article em En | MEDLINE | ID: mdl-35244769
ABSTRACT

BACKGROUND:

Upregulated Kindlin-2 expression in hepatocellular carcinoma (HCC) correlates with metastasis and poor prognosis. In this study, we investigated the molecular mechanism of Kindlin-2 in HCC.

METHODS:

Kindlin-2 downstream pathways were explored through microRNA sequencing. The Kindlin-2-miR-1258-TCF4 axis was verified using bisulfite sequencing, a luciferase reporter assay, quantitative real-time PCR, and rescue assays. Binding of TCF4 to the Kindlin-2 promoter was confirmed by promoter activity analysis and chromatin immunoprecipitation.

RESULTS:

MiRNA sequencing identified miR-1258 as a downstream effector of Kindlin-2. MiR-1258 expression was increased following Kindlin-2 knockdown and decreased after Kindlin-2 overexpression. Next, we identified transcription factor 7 like 2 (TCF7L2 or TCF4) as a target of miR-1258 and found that Kindlin-2 upregulated TCF4 expression by epigenetically suppressing miR-1258 in HCC. Furthermore, our results suggest that TCF4 binds to the Kindlin-2 promotor to enhance its transcription. Therefore, Kindlin-2-miR-1258-TCF4 interaction creates a positive feedback loop. Functional assays and animal experiments demonstrated critical roles of miR-1258 and TCF4 in HCC cell migration in vitro and HCC metastasis in vivo. In HCC tissues, Kindlin-2 expression correlated negatively with miR-1258 expression and positively with TCF4 expression. Meanwhile, miR-1258 expression correlated negatively with TCF4 expression.

CONCLUSIONS:

This study illustrates a novel integrin-independent signaling pathway, Kindlin-2-miR-1258-TCF4, that regulates HCC invasion and metastasis and identifies Kindlin-2 as a promising therapeutic target in HCC.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / MicroRNAs / Fator de Transcrição 4 / Neoplasias Hepáticas / Proteínas de Membrana / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / MicroRNAs / Fator de Transcrição 4 / Neoplasias Hepáticas / Proteínas de Membrana / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article